189 related articles for article (PubMed ID: 31669784)
21. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
[TBL] [Abstract][Full Text] [Related]
22. Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients.
Ricca I; Rocci A; Drandi D; Francese R; Compagno M; Lobetti Bodoni C; De Marco F; Astolfi M; Monitillo L; Vallet S; Calvi R; Ficara F; Omedè P; Rosato R; Gallamini A; Marinone C; Bergui L; Boccadoro M; Tarella C; Ladetto M
Leukemia; 2007 Apr; 21(4):697-705. PubMed ID: 17301820
[TBL] [Abstract][Full Text] [Related]
23. Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.
Van Damme M; Crompot E; Meuleman N; Mineur P; Dessars B; El Housni H; Bron D; Lagneaux L; Stamatopoulos B
Epigenetics; 2014 Oct; 9(10):1374-81. PubMed ID: 25437053
[TBL] [Abstract][Full Text] [Related]
24. Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia.
Stamatopoulos B; Van Damme M; Crompot E; Dessars B; Housni HE; Mineur P; Meuleman N; Bron D; Lagneaux L
Mol Med; 2015 Jan; 21(1):123-33. PubMed ID: 25584781
[TBL] [Abstract][Full Text] [Related]
25. Measurement of miRNAs in Chronic Lymphocytic Leukemia Patient Samples by Quantitative Reverse Transcription PCR.
Van Roosbroeck K; Bayraktar R; Calin GA
Methods Mol Biol; 2019; 1881():267-276. PubMed ID: 30350212
[TBL] [Abstract][Full Text] [Related]
26. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
27. GALNT11 as a new molecular marker in chronic lymphocytic leukemia.
Libisch MG; Casás M; Chiribao M; Moreno P; Cayota A; Osinaga E; Oppezzo P; Robello C
Gene; 2014 Jan; 533(1):270-9. PubMed ID: 24076351
[TBL] [Abstract][Full Text] [Related]
28. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
29. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
30. Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
Gao R; Man TS; Liang JH; Wang L; Zhu HY; Wu W; Fan L; Li JY; Yang T; Xu W
Cancer Res Treat; 2020 Jan; 52(1):189-206. PubMed ID: 31291713
[TBL] [Abstract][Full Text] [Related]
31. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Giannarelli D; Sperduti I; Molica M; Gentile M; Morabito F; Neri A; Ferrarini M
Int J Hematol; 2008 Nov; 88(4):374-380. PubMed ID: 18818986
[TBL] [Abstract][Full Text] [Related]
32. tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature.
Karousi P; Papanota AM; Artemaki PI; Liacos CI; Patseas D; Mavrianou-Koutsoukou N; Liosi AA; Kalioraki MA; Ntanasis-Stathopoulos I; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Scorilas A; Terpos E; Kontos CK
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944627
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
35. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
[TBL] [Abstract][Full Text] [Related]
36. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia.
Stamatopoulos B; Meuleman N; Haibe-Kains B; Duvillier H; Massy M; Martiat P; Bron D; Lagneaux L
Clin Chem; 2007 Oct; 53(10):1757-66. PubMed ID: 17702857
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL).
Asaad NY; Abd El-Wahed MM; Dawoud MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815
[TBL] [Abstract][Full Text] [Related]
38. The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia.
Miller CR; Ruppert AS; Fobare S; Chen TL; Liu C; Lehman A; Blachly JS; Zhang X; Lucas DM; Grever MR; Tallman MS; Flinn IW; Rassenti LZ; Kipps TJ; Sampath D; Coombes KR; Hertlein EK
Oncotarget; 2017 Apr; 8(16):25942-25954. PubMed ID: 28412730
[TBL] [Abstract][Full Text] [Related]
39. Complex karyotype as a predictor of high-risk chronic lymphocytic leukemia: A single center experience over 12 years.
Kruzova L; Schneiderova P; Holzerova M; Vatolikova M; Divoka M; Turcsanyi P; Urbanova R; Kudelka M; Radvansky M; Kriegova E; Papajik T; Urbankova H
Leuk Res; 2019 Oct; 85():106218. PubMed ID: 31476701
[TBL] [Abstract][Full Text] [Related]
40. Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.
Pflug N; Bahlo J; Shanafelt TD; Eichhorst BF; Bergmann MA; Elter T; Bauer K; Malchau G; Rabe KG; Stilgenbauer S; Döhner H; Jäger U; Eckart MJ; Hopfinger G; Busch R; Fink AM; Wendtner CM; Fischer K; Kay NE; Hallek M
Blood; 2014 Jul; 124(1):49-62. PubMed ID: 24797299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
